Conduit Pharmaceuticals- Warrants (22/09/2028) Profit Margin

Conduit Pharmaceuticals- Warrants (22/09/2028)'s profit margin stands at 12.85% as of June 2026. That compares with 6.29% in the prior-year period — up 104.5% year over year. That is below the sector sector average of 13.23%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Conduit Pharmaceuticals- Warrants (22/09/2028) reported 12.85% in profit margin versus 6.29% a year earlier — a 104.5% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

Conduit Pharmaceuticals- Warrants (22/09/2028) sits lower the its sector benchmark (13.23%) with a profit margin of 12.85%. That is roughly 2.8% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of 12.85% for Conduit Pharmaceuticals- Warrants (22/09/2028) means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Conduit Pharmaceuticals- Warrants (22/09/2028)'s profit margin evolved across reporting periods, while the comparison chart places CDTTW next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.